5TX.F SENSUS HEALTHCARE DL-01
- Market cap
- EUR 48.4M
- P/E
- -
- P/B
- 1.39x
- ROE
- -61.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 5TX.F undervalued?
Graham numberThe Graham number of SENSUS HEALTHCARE DL-01 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SENSUS HEALTHCARE DL-01 fundamental analysis
No fundamental analysis for SENSUS HEALTHCARE DL-01 yet.
SENSUS HEALTHCARE DL-01 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SENSUS HEALTHCARE DL-01
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin ca…
Full company profileSENSUS HEALTHCARE DL-01 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SENSUS HEALTHCARE DL-01 annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 27.0M | 44.5M | 24.4M | 41.8M | 27.5M | 11.4M |
| Gross Profit | 17.0M | 29.6M | 14.1M | 24.4M | 11.9M | 3.52M |
| Operating Income | 4.12M | 14.8M | -382K | 8.09M | -10.3M | -15.1M |
| EBITDA | - | 15.3M | 79.0K | 8.52M | -9.68M | -14.5M |
| Net Income | 4.12M | 24.2M | 485K | 6.65M | -7.72M | -22.8M |
| EPS | 0.25 | 1.48 | 0.03 | 0.40 | -0.47 | -1.38 |
| Balance Sheet | ||||||
| Total Assets | 32.2M | 56.7M | 53.7M | 62.2M | 53.0M | 41.3M |
| Total Liabilities | 6.23M | 8.67M | 4.87M | 6.34M | 4.94M | 4.40M |
| Shareholders' Equity | 26.0M | 48.1M | 48.8M | 55.8M | 48.1M | 36.9M |
| Cash & Short-term Investments | 14.5M | 25.5M | 23.1M | 22.1M | 22.1M | 15.2M |
| Cash Flow | ||||||
| Operating Cash Flow | -286K | -1.41M | -2.15M | -831K | 528K | -13.8M |
| Capital Expenditure | 128K | 159K | 229K | 276K | 196K | 22.0K |
| Free Cash Flow | -414K | -1.57M | -2.37M | -1.11M | 332K | -13.8M |
| Ratios | ||||||
| ROE | 15.8% | 50.4% | 1.0% | 11.9% | -16.0% | -61.7% |
| ROA | 12.8% | 42.7% | 0.9% | 10.7% | -14.6% | -55.1% |
| Net Profit Margin | 15.2% | 54.4% | 2.0% | 15.9% | -28.1% | -200.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
SENSUS HEALTHCARE DL-01 dividends
SENSUS HEALTHCARE DL-01 has not paid dividends in the last 5 fiscal years.
Who owns SENSUS HEALTHCARE DL-01
- Insiders 18.67%
- Institutions 27.74%
- Public & others 53.59%
- Shares outstanding 16.5M
- Free float 13.4M
SENSUS HEALTHCARE DL-01 company profile
- Company name
- SENSUS HEALTHCARE DL-01
- Ticker
- 5TX.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 60
- Fiscal year end
- December
- Address
- 851 Broken Sound Parkway NW, Boca Raton, FL, United States, 33487
- Phone
- 561 922 5808
- Website
- sensushealthcare.com
About SENSUS HEALTHCARE DL-01
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.
SENSUS HEALTHCARE DL-01 management
6- Mr. Joseph C. SardanoCo-Founder, Chairman & CEO · born 1953
- Mr. Michael J. Sardano J.D.President, Chief Commercial Officer, General Counsel, Corporate Secretary & Director · born 1988
- Mr. Javier RampollaChief Financial Officer · born 1973
- Ms. Magdalena MartinezChief Operating Officer · born 1990
- Mr. Carlton ChowChief Technology Officer · born 1990
- Ms. Stephanie TiptonVice President of Marketing